Cargando…

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019

IMPORTANCE: The closure of the Medicare Part D coverage gap from 2010 to 2019 was intended to help decrease out-of-pocket costs for beneficiaries, especially those taking high-cost drugs. However, yearly increases in list prices and the introduction of newer and more expensive drugs may have limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erath, Alexandra, Dusetzina, Stacie B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186858/ https://www.ncbi.nlm.nih.gov/pubmed/32338754 http://dx.doi.org/10.1001/jamanetworkopen.2020.3969

Ejemplares similares

Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit
por: Rotenstein, Lisa S., et al.
Publicado: (2018)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
por: Gupta, Arjun, et al.
Publicado: (2022)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Changes in Out-of-Pocket Spending and Catastrophic Health Care Expenditures Associated With Medicare Eligibility
por: Scott, John W., et al.
Publicado: (2021)

Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?
por: Fong, Joelle H.
Publicado: (2019)

Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
por: Jazowski, Shelley A., et al.
Publicado: (2022)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Out-of-pocket spending for contraceptives in Latin America
por: Garraza, Lucas Godoy, et al.
Publicado: (2020)

The role of consumer choice in out-of-pocket spending on health
por: Nübler, Laura, et al.
Publicado: (2023)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
por: Lakdawalla, Darius, et al.
Publicado: (2021)

High Out-of-Pocket Health Spending in Countries With a Mediterranean Connection
por: Grima, Simon, et al.
Publicado: (2018)

Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures
por: Jbaily, Abdulrahman, et al.
Publicado: (2021)

Communication between cancer patients, caregivers and oncologists about out-of-pocket spending
por: Tur-Sinai, A, et al.
Publicado: (2022)

A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021)

Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)

State-Level Variation in Medicare Spending
por: Gage, Barbara, et al.
Publicado: (1999)

Investigating determinants of out-of-pocket spending and strategies for coping with payments for healthcare in southeast Nigeria
por: Onwujekwe, Obinna E, et al.
Publicado: (2010)

The use of and out-of-pocket spending on complementary and alternative medicine in Qassim province, Saudi Arabia
por: AlBedah, Abdullah M. N., et al.
Publicado: (2013)

Inequity & burden of out-of-pocket health spending: District level evidences from India
por: Chowdhury, Samik, et al.
Publicado: (2018)

The Impact of Business Cycle on Health Financing: Subsidized, Voluntary and Out-of-Pocket Health Spending
por: Dong, Hao, et al.
Publicado: (2020)

Out-of-Pocket Spending Within 90 Days of Discharge from COVID-19 Hospitalization
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Income Shocks and Out-of-Pocket Health Care Spending: Implications for Single-Mother Families
por: Grafova, Irina B., et al.
Publicado: (2021)

Determinants of Out-of-Pocket Health Spending in Households in Peru in the Times of the Pandemic (COVID-19)
por: Quispe Mamani, Julio Cesar, et al.
Publicado: (2023)

Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
por: Dean, Emma Boswell, et al.
Publicado: (2021)

Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
por: Dickson, Sean R., et al.
Publicado: (2023)

Progressivity of out-of-pocket costs for Medicare-subsidised services and medicines in Australia.
por: Di Law, Hsei, et al.
Publicado: (2022)

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019
por: Tringale, Kathryn R., et al.
Publicado: (2022)

COUNTRIES ARE SPENDING MORE ON HEALTH, BUT PEOPLE ARE STILL PAYING TOO MUCH OUT OF THEIR OWN POCKETS
Publicado: (2019)

Economic Burden of Out-of-Pocket Spending for Plastic Surgery Procedures: Value From the Patient’s Perspective
por: Billig, Jessica I., et al.
Publicado: (2019)

Access to High-Cost Medications After a Cap on Monthly Out-of-Pocket Spending in California
por: Taylor, Erin Audrey, et al.
Publicado: (2021)

Understanding out-of-pocket spending and financial hardship among patients who succumb to cancer and their caregivers
por: Tur-Sinai, Aviad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2krq9fp7nb62odet9g0hdm7pj